Lesion [sources] | ICD-10 | Crude annual incidence rate per 100.000 men or women | Estimated number of new annual cases in 2016 in Spain (95% CI) |
---|---|---|---|
Genital warts (men) [11] | NA | 136.60 | 31,163 (30,806–31,497) |
Genital warts (women) [11] | NA | 99.60 | 23,560 (23,238–23,839) |
CIN 2/3 [13,15] | NA | 142.02 | 33,594 (33,235–33,953) |
VIN2/3 [13,15] | NA | 6.02 | 1424 (1350–1498) |
VaIN 2/3 [13,15] | NA | 1.02 | 241 (210–271) |
NA | 0.57 | 130 (108–153) | |
NA | 0.27 | 63 (47–78) | |
PIN 2/3 [13, 17] | NA | 1.32 | 302 (268–336) |
Cervical cancer [13] | C53 | 10.10 | 2389 (2293–2485) |
C51 | 2.77 | 655 (556–754) | |
C52 | 0.47 | 111 (70–151) | |
C21 | 0.86 | 197 (143–250) | |
C21 | 0.68 | 160 (111–209) | |
C60 | 1.91 | 436 (356–516) | |
C02–06 | 7.55 | 1724 (1492–1955) | |
C02–06 | 0.64 | 736 (574–876) | |
C11 | 1.54 | 352 (277–426) | |
C11 | 0.45 | 106 (65–148) | |
C01, C09, C10 | 1.64 | 1066 (841–1290) | |
C01, C09, C10 | 0.10 | 152 (68–233) | |
C12–13 | 3.62 | 826 (711–940) | |
C12–13 | 0.25 | 59 (28–89) | |
C14 | 1.05 | 240 (179–302) | |
C14 | 0.13 | 32 (9–54) | |
C32 | 16.72 | 3815 (3569–4060) | |
C32 | 0.92 | 217 (158–276) |